42 results on '"de Haan, Judith J"'
Search Results
2. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis
3. How open science can support the 3Rs and improve animal research.
4. Meaningful public engagement in the context of open science: reflections from early and mid-career academics
5. Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling
6. Meaningful public engagement in the context of open science: reflections of early and mid-career academics
7. Meaningful public engagement in the context of open science: reflections of early and mid-career academics
8. CXCL4 drives fibrosis by promoting several key cellular and molecular processes
9. Referee report. For: MapOSR - A mapping review dataset of empirical studies on Open Science [version 1; peer review: 1 approved, 1 approved with reservations]
10. A 3-year evaluation of preclinicaltrials.eu reveals room for improvement in preregistration of animal studies
11. The Extracellular Matrix Modulates Fibroblast Phenotype and Function in the Infarcted Myocardium
12. Open Science Monitor 2020 Utrecht University: Commissioned by the Utrecht University Open Science Programme
13. A 3-year evaluation of preclinicaltrials.eu reveals room for improvement in preregistration of animal studies
14. Open Science Monitor 2020 Utrecht University: Commissioned by the Utrecht University Open Science Programme
15. The transverse aortic constriction heart failure animal model:a systematic review and meta-analysis
16. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis
17. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis
18. The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases
19. Corrigendum to: Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure (vol 279, pg 141, 2019)
20. The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases
21. The therapeutic potential of targeting CD40-TRAF6 pathway in cardiovascular Diseases
22. Corrigendum to ‘Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure’ [Int. J. Cardiol., Volume 279, 15 March 2019, Pages 141-144]
23. Corrigendum to: Small molecule-mediated inhibition of CD40-TRAF6 reduces adverse cardiac remodelling in pressure overload induced heart failure (vol 279, pg 141, 2019)
24. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice
25. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice
26. Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease
27. Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload
28. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice
29. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice
30. Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease
31. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
32. Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload
33. Complement 5a Receptor deficiency does not influence adverse cardiac remodeling after pressure-overload in mice
34. Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice
35. Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease
36. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
37. Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload
38. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
39. Endogenous tissue transglutaminase critically regulates cardiac remodeling through distinct enzymatic and non‐enzymatic actions
40. Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: A histopathological study in carotid plaques
41. Sa1889 Toll-Like Receptor 2 Enhanced Lysosomal Activity and Endocytosis in a Barrett's Esophagus Cell Line
42. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.